ADAM29 | ADAM metallopeptidase domain 29 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM32 | ADAM metallopeptidase domain 32 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM33 | ADAM metallopeptidase domain 33 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ADAM7 | ADAM metallopeptidase domain 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM9 | ADAM metallopeptidase domain 9 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAMTS10 | ADAM metallopeptidase with thrombospondin type 1 motif, 10 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS18 | ADAM metallopeptidase with thrombospondin type 1 motif, 18 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Mixed |
ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Not detected |
ADAMTS3 | ADAM metallopeptidase with thrombospondin type 1 motif, 3 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Mixed |
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Mixed |
ADAMTS7 | ADAM metallopeptidase with thrombospondin type 1 motif, 7 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL1 | ADAMTS-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTSL2 | ADAMTS-like 2 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL5 | ADAMTS-like 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAP1 | ArfGAP with dual PH domains 1 | Predicted intracellular proteins
| | | | | Mixed |
ADCK1 | AarF domain containing kinase 1 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ADCY6 | Adenylate cyclase 6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCYAP1R1 | Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
ADI1 | Acireductone dioxygenase 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADIG | Adipogenin | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADM | Adrenomedullin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADM2 | Adrenomedullin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
ADPGK | ADP-dependent glucokinase | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADPRH | ADP-ribosylarginine hydrolase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
ADPRHL1 | ADP-ribosylhydrolase like 1 | Predicted intracellular proteins
| | | | | Group enriched |
ADPRHL2 | ADP-ribosylhydrolase like 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ADRM1 | Adhesion regulating molecule 1 | Predicted intracellular proteins
| | | | | Expressed in all |
AEBP1 | AE binding protein 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
AFM | Afamin | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AGA | Aspartylglucosaminidase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
AGER | Advanced glycosylation end product-specific receptor | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
AGK | Acylglycerol kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AGPS | Alkylglycerone phosphate synthase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
AGR2 | Anterior gradient 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |